Get the Stockscreener App
9.53
4.60%
-0.46
After Hours:
9.53
Lumexa Imaging Holdings Inc stock is traded at $9.53, with a volume of 962.76K.
It is down -4.60% in the last 24 hours and down -21.82% over the past month.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
See More
Previous Close:
$9.99
Open:
$9.95
24h Volume:
962.76K
Relative Volume:
1.16
Market Cap:
$915.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-16.91
EPS:
-0.5635
Net Cash Flow:
-
1W Performance:
+0.11%
1M Performance:
-21.82%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.36
$10.35
1-Week Range:
$9.00
$10.35
52-Week Range:
$7.23
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Name
Lumexa Imaging Holdings Inc
Sector
Industry
Phone
704-334-7830
Address
4200 SIX FORKS ROAD, RALEIGH
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
9.53 | 960.14M | 0 | 0 | 0 | -0.5635 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-05-26 | Initiated | Barclays | Overweight |
| Jan-05-26 | Initiated | Deutsche Bank | Buy |
| Jan-05-26 | Initiated | JP Morgan | Overweight |
| Jan-05-26 | Initiated | Jefferies | Buy |
| Jan-05-26 | Initiated | Leerink Partners | Outperform |
| Jan-05-26 | Initiated | Raymond James | Outperform |
| Jan-05-26 | Initiated | Wells Fargo | Overweight |
| Jan-05-26 | Initiated | William Blair | Outperform |
View All
Lumexa Imaging Holdings Inc Stock (LMRI) Latest News
Top Lumexa Imaging (LMRI) Competitors 2026 - MarketBeat
Jefferies reiterates Lumexa Imaging stock rating on demand outlook By Investing.com - Investing.com Canada
LMRI Maintains Overweight by Barclays -- Price Target Lowered to $15.00 - GuruFocus
Lumexa Imaging price target lowered to $15 from $23 at Barclays - TipRanks
Analysts’ Top Technology Picks: IonQ (IONQ), Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Lumexa Imaging reiterates 2026 guidance during site visit By Investing.com - Investing.com Australia
Lumexa Imaging reiterates 2026 guidance during site visit - Investing.com
Lumexa Imaging Holdings IncReiterates full year 2026 guidance on April 8, 2026SEC filing - marketscreener.com
Lumexa Imaging Reaffirms Full-Year 2026 Financial Guidance - TipRanks
Lumexa Imaging reiterates full-year 2026 guidance after site visit - TradingView — Track All Markets
Lumexa Imaging (LMRI) reiterates previously disclosed full-year 2026 guidance - Stock Titan
Should I buy Lumexa Imaging Holdings, Inc. (LMRI) - Zacks Investment Research
Lumexa Imaging Holdings, Inc. Common Stock Stock Forecast Summary - Meyka
Lumexa Imaging Earnings Call Highlights Growth Momentum - TipRanks
Earnings Call Summary | Lumexa Imaging(LMRI.US) Q4 2025 Earnings Conference - 富途牛牛
Maintaining Buy on LMRI: Market Overdiscounts Consolidated Centers, Creating Upside to $17 Target - TipRanks
Raymond James cuts Lumexa Imaging stock price target on soft outlook - Investing.com Canada
Lumexa Imaging price target lowered to $17 from $23 at Raymond James - TipRanks
Jefferies reiterates Lumexa Imaging stock rating citing growth outlook By Investing.com - Investing.com Canada
LMRI SEC FilingsLumexa Imaging Holdings 10-K, 10-Q, 8-K Forms - Stock Titan
Lumexa Imaging (NASDAQ: LMRI) hits $1.023B revenue and raises $427M IPO - Stock Titan
Lumexa Imaging: Clearer Growth Path Ahead (NASDAQ:LMRI) - Seeking Alpha
LMRI Technical Analysis & Stock Price Forecast - Intellectia AI
Analysts Offer Insights on Technology Companies: Intuit (INTU), Rubrik, Inc. Class A (RBRK) and Lumexa Imaging Holdings, Inc. (LMRI) - theglobeandmail.com
Analysts Offer Insights on Technology Companies: Lumexa Imaging Holdings, Inc. (LMRI), Adobe (ADBE) and Blaize Holdings (BZAI) - The Globe and Mail
Lumexa Imaging Reports Strong Q4 and Full Year 2025 Results, Reiterates 2026 Guidance and Outlines Growth Strategy - Minichart
Lumexa Imaging Posts Strong Q4 Growth, Reaffirms 2026 Outlook - TipRanks
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged - GlobeNewswire
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Earnings call transcript: Lumexa Imaging Q4 2025 reveals unexpected EPS miss - Investing.com Canada
Leerink reiterates Outperform on Lumexa Imaging stock at $23 By Investing.com - Investing.com Canada
Leerink reiterates Outperform on Lumexa Imaging stock at $23 - Investing.com
Lumexa Imaging Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance - Bitget
Lumexa Imaging Holdings Inc has released its financial guidance for 2026, expecting adjusted EBITDA to be between $234 million and $242 million. - Bitget
Lumexa Imaging Q4 Loss Widens, Revenue Rises; Issues 2026 Adjusted EPS Guidance - MarketScreener
Lumexa: Q4 Earnings Snapshot - MarketScreener
Lumexa Imaging (Nasdaq: LMRI) grows 2025 revenue, cuts debt and loss - Stock Titan
Earnings Flash (LMRI) Lumexa Imaging Posts Preliminary Q4 Loss $0.38 a Share - marketscreener.com
Earnings Flash (LMRI) Lumexa Imaging Holdings, Inc. Reports Q4 Revenue $267.7M, vs. FactSet Est of $261.2M - MarketScreener
Lumexa says new imaging centers and scan demand lifted EBITDA 19% - Stock Titan
Raymond James reiterates Strong Buy on Lumexa Imaging stock - Investing.com UK
Raymond James reiterates Strong Buy on Lumexa Imaging stock By Investing.com - Investing.com India
Raymond James says helium concerns behind Radnet stock sell-off overblown - Investing.com Canada
Raymond James says helium concerns behind Radnet stock sell-off overblown By Investing.com - za.investing.com
Lumexa Imaging Holdings Inc Stock (LMRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):